Germany
Japan
United Kingdom
China
Rabbit Polyclonal Nestin Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | DNA immunization. This antibody is specific for the C Terminus Region of the target protein. |
Primary Antibodies
View as table Download
PIM1 Antibody (C-term ) Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PIM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 374-404 amino acids from the C-terminal region of human PIM1. |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Rabbit Polyclonal CCR5 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | CCR5 antibody was raised against a 15 amino acid peptide near the amino terminus of human CCR5. The immunogen is located within the first 50 amino acids of CCR5. |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
WISP2 Rabbit Polyclonal (aa102-117) Antibody
| Applications | IHC |
| Reactivities | Human |
| Immunogen | WISP2 antibody was raised against synthetic peptide from human WISP2. |
Phospho-KDR-Y1175 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y1175 of human KDR |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against SOX2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SOX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 89-119 amino acids from the N-terminal region of human SOX2. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
Thy-1 / CD90 Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human, Monkey, Orang-Utan |
| Conjugation | Unconjugated |
| Immunogen | THY1 / CD90 antibody was raised against synthetic peptide C-PEHTYRSRTNFTSKY from an internal region of human THY1 (NP_006279.2). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset (100%); Panda, Dog, Horse (93%); Pig (87%); Elephant, Rabbit, Guinea pig (80%). |
Rabbit polyclonal KLF4 Antibody (C-term)
| Applications | FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 394-421 amino acids from the C-terminal region of human KLF4. |
Rabbit Polyclonal c-Jun (Ser73) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human c-Jun around the phosphorylation site of Serine 73 |
| Modifications | Phospho-specific |
Anti-Human IGF-I Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human IGF-I |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human ACTB |
Rabbit Polyclonal Anti-DKK2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human DKK2 |
Rabbit polyclonal SOX-9 (Ser181) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human SOX-9 around the phosphorylation site of serine 181 (R-K-SP-V-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal PDGFR beta (Ab-1021) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PDGFR β around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I). |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Rabbit polyclonal anti-G-CSF antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide surrounding amino acid 195 of human G-CSF |
Rabbit polyclonal anti-GM-CSF antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This purified antibody was prepared from whole rabbit serum produced by repeated immunizations with full length recombinant human GM-CSF protein. |
Rabbit polyclonal KLF4 Antibody (N-term)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 20-53 amino acids from the N-terminal region of human KLF4. |
Rabbit Polyclonal Akt (Thr308) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Akt around the phosphorylation site of Threonine 308 |
| Modifications | Phospho-specific |
Rabbit Polyclonal C/EBP- beta (Thr235/188) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human C/EBP- beta around the phosphorylation site of Threonine 235/188 |
| Modifications | Phospho-specific |
Rabbit Polyclonal AML1 (Ser276) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AML1 around the phosphorylation site of Serine 276 |
| Modifications | Phospho-specific |
Rabbit Polyclonal AML1 (Ser303) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AML1 around the phosphorylation site of Serine 303 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Src (Tyr418) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Src around the phosphorylation site of Tyrosine 418 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Src (Tyr529) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Src around the phosphorylation site of Tyrosine 529 |
| Modifications | Phospho-specific |
Rabbit polyclonal c-Jun (Phospho-Ser63) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human c-Jun around the phosphorylation site of Serine 63. |
| Modifications | Phospho-specific |
Active filters
Clonalities
- Polyclonal
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Category
Target Symbol
- EGFR (26)
- AKT1 (18)
- JUN (15)
- CD44 (13)
- PDGFRB (11)
- SRC (10)
- CTNNB1 (8)
- FN1 (8)
- PRKCA (8)
- RUNX1 (8)
- STAT5A (8)
- CDH1 (7)
- GAPDH (7)
- GCG (7)
- MAPK3 (7)
- SMAD1 (7)
- BCL2L1 (6)
- CASP3 (6)
- CEBPA (6)
- MAPK8 (6)
- MYB (6)
- SMAD3 (6)
- STAT5B (6)
- TNC (6)
- ACTB (5)
- AKT2 (5)
- BCL2 (5)
- CCR5 (5)
- HNF1B (5)
- KDR (5)
- TNNI3 (5)
- CDH5 (4)
- GATA1 (4)
- GATA3 (4)
- GATA4 (4)
- GFAP (4)
- ITGA6 (4)
- KIT (4)
- PECAM1 (4)
- PTPRC (4)
- SMAD2 (4)
- SOX2 (4)
- SP1 (4)
- VCAM1 (4)
- VIM (4)
- YBX1 (4)
- ACE (3)
- ANGPT1 (3)
- BDNF (3)
- BMI1 (3)
- BSG (3)
- CD4 (3)
- CDX2 (3)
- CSF2 (3)
- CSNK1A1 (3)
- CXCR4 (3)
- HCRTR1 (3)
- ICAM1 (3)
- ID4 (3)
- ITGB3 (3)
- KLF4 (3)
- NES (3)
- NOTCH1 (3)
- PIK3CG (3)
- SERPINA1 (3)
- STAT6 (3)
- TEK (3)
- THY1 (3)
- TNFRSF8 (3)
- TUBB3 (3)
- A1BG (2)
- ABCB1 (2)
- ABCG2 (2)
- ACTN1 (2)
- ADGRE5 (2)
- AKT3 (2)
- ALDH1A1 (2)
- BGLAP (2)
- CCN3 (2)
- CD93 (2)
- CDCA4 (2)
- CDH2 (2)
- CEBPB (2)
- CSF1 (2)
- CSNK2A1 (2)
- CST3 (2)
- CYP3A4 (2)
- DHH (2)
- DKK2 (2)
- DKK4 (2)
- EGF (2)
- ENPEP (2)
- ETV1 (2)
- FAS (2)
- FCGR2A (2)
- FCGR2B (2)
- FGF18 (2)
- FGF21 (2)
- FGF7 (2)
- FLT3 (2)
Reactivities
Applications
Antibody Hosts
Conjugates
Modifications
Pathways
- Pathways in cancer (234)
- Focal adhesion (175)
- Colorectal cancer (131)
- MAPK signaling pathway (121)
- ErbB signaling pathway (117)
- Prostate cancer (96)
- Melanoma (94)
- Regulation of actin cytoskeleton (93)
- Glioma (86)
- Pancreatic cancer (86)
- Cytokine-cytokine receptor interaction (84)
- Endometrial cancer (82)
- Adherens junction (80)
- Wnt signaling pathway (76)
- Acute myeloid leukemia (74)
- GnRH signaling pathway (74)
- Non-small cell lung cancer (71)
- Gap junction (70)
- Chronic myeloid leukemia (69)
- Neurotrophin signaling pathway (65)
- Epithelial cell signaling in Helicobacter pylori infection (64)
- Jak-STAT signaling pathway (64)
- Endocytosis (63)
- T cell receptor signaling pathway (62)
- Tight junction (60)
- VEGF signaling pathway (58)
- Small cell lung cancer (57)
- Toll-like receptor signaling pathway (57)
- Cell adhesion molecules (CAMs) (56)
- Leukocyte transendothelial migration (55)
- Fc epsilon RI signaling pathway (53)
- Fc gamma R-mediated phagocytosis (53)
- B cell receptor signaling pathway (52)
- Renal cell carcinoma (52)
- Chemokine signaling pathway (49)
- Hematopoietic cell lineage (49)
- Apoptosis (47)
- Calcium signaling pathway (47)
- Progesterone-mediated oocyte maturation (46)
- Insulin signaling pathway (45)
- TGF-beta signaling pathway (45)
- ECM-receptor interaction (44)
- Bladder cancer (42)
- Melanogenesis (39)
- mTOR signaling pathway (39)
- Natural killer cell mediated cytotoxicity (38)
- Dorso-ventral axis formation (36)
- Adipocytokine signaling pathway (34)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (34)
- Pathogenic Escherichia coli infection (33)
- Hypertrophic cardiomyopathy (HCM) (30)
- Basal cell carcinoma (27)
- Dilated cardiomyopathy (27)
- Thyroid cancer (24)
- Alzheimer's disease (23)
- Type II diabetes mellitus (22)
- Hedgehog signaling pathway (20)
- Amyotrophic lateral sclerosis (ALS) (18)
- Long-term depression (17)
- Metabolic pathways (16)
- Viral myocarditis (16)
- Long-term potentiation (15)
- Maturity onset diabetes of the young (15)
- Vascular smooth muscle contraction (15)
- NOD-like receptor signaling pathway (14)
- Axon guidance (13)
- Huntington's disease (13)
- Prion diseases (13)
- Vibrio cholerae infection (13)
- Oocyte meiosis (11)
- Phosphatidylinositol signaling system (11)
- Cell cycle (10)
- p53 signaling pathway (10)
- Notch signaling pathway (9)
- Systemic lupus erythematosus (9)
- Glycolysis / Gluconeogenesis (8)
- Primary immunodeficiency (7)
- RIG-I-like receptor signaling pathway (7)
- Autoimmune thyroid disease (6)
- Neuroactive ligand-receptor interaction (6)
- Parkinson's disease (6)
- Renin-angiotensin system (6)
- Antigen processing and presentation (5)
- Cardiac muscle contraction (5)
- Complement and coagulation cascades (5)
- Type I diabetes mellitus (5)
- ABC transporters (4)
- Allograft rejection (4)
- Retinol metabolism (4)
- Graft-versus-host disease (3)
- Inositol phosphate metabolism (3)
- Tyrosine metabolism (3)
- Cysteine and methionine metabolism (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Lysosome (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Phenylalanine (2)
- Phenylalanine metabolism (2)
- Regulation of autophagy (2)
- Ubiquinone and other terpenoid-quinone biosynthesis (2)
- tyrosine and tryptophan biosynthesis (2)
- Asthma (1)
- Citrate cycle (TCA cycle) (1)
- Glutathione metabolism (1)
- PPAR signaling pathway (1)
- Pyruvate metabolism (1)
- Ubiquitin mediated proteolysis (1)